Injectable sustained-release risperidone: recurrence of delirium and treatment failure.
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003693:Delirium / Q000139:chemically induced*; D005602:France; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D007267:Injections; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D017211:Treatment Failure
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D018967:Risperidone